• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by DIH Holdings US Inc.

    2/20/24 5:18:47 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email
    SC 13D 1 tm246754d1_sc13d.htm SC 13D

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13D
     

    Under the Securities Exchange Act of 1934 (Amendment No. __) 

     

    DIH Holding US, Inc.
    (Name of Issuer)
     
     Common Stock, par value $0.0001 per share
    (Title of Class of Securities)
     
    23290B106
    (CUSIP Number)

     

     

    Jihai Jason Chen

    77 Accord Park Dr., Suite D-1

    Norwell, MA 02061, USA

    Tel: 858 472 3071 

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    February 7, 2024
    (Date of Event which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ¨.

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7(b) for other parties to whom copies are to be sent.

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    SCHEDULE 13D

     

    CUSIP No. 23290B106

     

    1

    NAMES OF REPORTING PERSONS

    DIH TECHNOLOGY LTD. (non-US Entity)

     

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    98-1639432
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  ¨

    (b)  ¨

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)

     

    WC

    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
    ¨
    6 CITIZENSHIP OR PLACE OF ORGANIZATION

     Cayman Islands 

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    14,085,241
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    14,085,241
    10 SHARED DISPOSITIVE POWER
    0

    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    14,085,241
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    ¨
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    34.73%
    14 TYPE OF REPORTING PERSON (See Instructions)
    CO

     

     

     

     SCHEDULE 13D

     

    CUSIP No. 23290B106

     

    1

    NAMES OF REPORTING PERSONS

    JIHAI JASON CHEN

     

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  ¨

    (b)  ¨

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)

     

    See item 3

    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
    ¨
    6 CITIZENSHIP OR PLACE OF ORGANIZATION

    United States 

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    See item 5
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    See item 5
    10 SHARED DISPOSITIVE POWER
    0

    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    See Item 5
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    ¨
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    See Item 5
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN

      

     

     

     

      Item 1.

    Security and Issuer 

     

    This statement relates to the Class A common stock, par value $0.0001 per share (“Class A Common Stock”), of DIH Holding US, Inc., a Delaware corporation (the “Company”). The address of the Company's principal executive office is 77 Accord Park Dr., Suite D-1 Norwell, MA 02061, USA.

     

      Item 2. Identity and Background

     

      (a) This Schedule 13D is filed by DIH TECHNOLOGY LTD., a Cayman Islands company (“DIH Technology”) and JIHAI Jason Chen (“Mr. Chen”), the Executive Director of DIH Technology and owner of 42% of the outstanding shares of DIH Technology (collectively, the “Reporting Persons”). Mr. Chen is a citizen of the United States. 

     

      (b)

    The principal business and principal office address for DIH Technology is P.O. Box 61, 3rd Floor Harbour Centre, North Church Street, Grand Cayman, KY1-1102, Cayman Islands. The principal business and principal office address for Mr. Chen is 77 Accord Park Dr., Suite D-1, Norwell, MA 02061, USA. 

     

      (c) DIH Technology is not involved in any business activity, other than holding the shares of the Company  as reflected in this Schedule 13D.   Mr. Chen is the Executive Director of DIH Technology and the Chief Executive Officer and Chairman of the Company.

     

      (d) During the past five years, neither (1) DIH Technology nor any of its officers or directors, nor (2) Mr. Chen, have been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors).

     

      (e) During the past five years, neither (1) DIH Technology nor any of its officers or directors, nor (2) Mr. Chen, have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     

      (f) Not applicable.

     

      Item 3. Source and Amount of Funds or Other Considerations

     

    DIH Technology was the parent company of DIH Holding US, Inc., a Nevada corporation which entered into the Business Combination (defined below). The Reported Shares were acquired pursuant to the transactions effected by the completion on February 7, 2024 of the business combination pursuant to the Business Combination Agreement, dated as of February 26, 2023, (as amended, the “BCA”) by and among Aurora Technology Acquisition Corp., a Cayman Islands exempted company (the “SPAC”), Aurora Technology Merger Sub Corp., a Nevada corporation, and DIH Holding US, Inc., a Nevada corporation (the “SPAC Business Combination”).

      

     

     

     

      Item 4. Purpose of Transaction

     

    DIH Technology’s acquisition of the Class A Common Stock was for investment purposes. DIH Technology does not have any plans or proposals which relate to or would result in: (a) the acquisition by any person of additional securities of the Company; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation , involving the Company or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Company or of any of its subsidiaries; (d) any change in the present board of directors or management of the Company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the Company; (f) any other material change in the Company’s business or corporate structure; (g) changes in the Company’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any other person; (h) causing a class of securities of the Company to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Company becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Act; or (j) any similar action to those enumerated above.

      

      Item 5. Interest in Securities of the Issuer

     

    (a)   DIH Technology is the beneficial owner of an aggregate of 14,085,241 shares of Class A Common Stock, representing approximately 34.73% of the total issued and outstanding shares of Class A Common Stock of the Company (the “Reported Shares”). Mr. Chen does not own any shares of the Company directly but may be deemed to have indirect ownership of the Reported Shares through his ownership of approximately 42% of the outstanding shares of DIH Technology and his position as Executive Director of DIH Technology. In his role as Executive Director of DIH Technology, and not individually, Mr. Chen may be deemed to have voting or dispositive power over the Reported Shares. Mr. Chen disclaims beneficial ownership over such Reported Shares, other than to the extent he may have a pecuniary interest therein, directly or indirectly.

     

    (b)   DIH Technology has the sole power to vote or to direct the vote, and sole power to dispose or direct the disposition of the Reported Shares. Through his ownership of approximately 42% of the outstanding shares of DIH Technology and his position as Executive Director of DIH Technology Mr. Chen, may be deemed to have power to vote or to direct the vote, and sole power to dispose or direct the disposition of the Reported Shares. Mr. Chen disclaims beneficial ownership over the Reported Shares, other than to the extent he may have a pecuniary interest therein, directly or indirectly.

     

    (c)   Neither Reporting Person has effected any transactions in the Class A Common Stock of the Company in the past sixty (60) days.

     

    (d)   No other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the shares owned by the Reporting Persons.

     

    (e)   Not applicable.

     

      Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

     

    Mr. Chen is the Chief Executive Officer and Chairman of the Company.

     

      Item 7. Material to Be Filed as Exhibits

      

    BCA (incorporated by reference from Annex A to the Prospectus filed by the SPAC, on November 15, 2023).    

      

     

     

     

    Signature

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 20, 2024

      

      DIH Technology Ltd.
         
      By: /s/ Jason Chen
      Name: Jason Chen
      Title:    Executive Director
         
      Jason Chen
         
      /s/ Jason Chen

     

     

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

     

      

     

     

    Get the next $DHAI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

    NORWELL, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) received a notice on July 29, 2025, from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq"), which stated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not filed its Annual Report on Form 10-K for the period ended March 31, 2025 with the Securities and Exchange Commission ("SEC"). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the SEC. Under Nasdaq rules, the Company has 60 calendar days from the date of the notice to file its Annual Report on F

    8/1/25 4:30:00 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Dennis Streppa to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Dennis Streppa to its Board of Directors and filling the Audit Committee Chair position. Dennis Streppa is a seasoned global Chief Operations Officer and entrepreneur with expertise spanning public and private healthcare companies. He's driven M&A value at Cardi

    7/18/25 5:00:56 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Burell Scott R claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    8/11/25 4:05:17 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Streppa Dennis claimed ownership of 78,022 shares (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    7/25/25 4:30:13 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Director Baucus Max was granted 52,817 shares (SEC Form 4)

    4 - DIH HOLDING US, INC. (0001883788) (Issuer)

    12/9/24 4:03:26 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    SEC Filings

    View All

    SEC Form DEF 14A filed by DIH Holdings US Inc.

    DEF 14A - DIH HOLDING US, INC. (0001883788) (Filer)

    8/26/25 9:15:24 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form NT 10-Q filed by DIH Holdings US Inc.

    NT 10-Q - DIH HOLDING US, INC. (0001883788) (Filer)

    8/15/25 8:00:23 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form PRE 14A filed by DIH Holdings US Inc.

    PRE 14A - DIH HOLDING US, INC. (0001883788) (Filer)

    8/13/25 9:00:04 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    View All

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    DIH Appoints Dennis Streppa to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Dennis Streppa to its Board of Directors and filling the Audit Committee Chair position. Dennis Streppa is a seasoned global Chief Operations Officer and entrepreneur with expertise spanning public and private healthcare companies. He's driven M&A value at Cardi

    7/18/25 5:00:56 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Professor Nick Ward, M.D., to DIH Scientific Advisory Board

    NORWELL, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Professor Nick Ward, M.D. to its Scientific Advisory Board. Nick Ward, M.D., is a Professor of Clinical Neurology and Neurorehabilitation at the Institute of Neurology at University College London and at the National Hospital for Neurology and Neurosurgery in Lo

    7/15/25 8:00:00 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 6:07:49 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 12:46:18 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by DIH Holdings US Inc.

    SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

    2/20/24 5:18:47 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care